Beurs gesloten -
Nasdaq
22:00:00 26-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
5,49
USD
|
+4,97%
|
|
+3,58%
|
-14,88%
|
Fiscaal tijdperk: december |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
721,4
|
848,3
|
266,7
|
272,3
|
233,7
|
-
|
-
|
Bedrijfswaarde
1 |
555,3
|
805,5
|
-79,1
|
272,3
|
137,4
|
6,234
|
178,5
|
K/w-verhouding
|
-3,25
x
|
-8,38
x
|
-2,44
x
|
-2,76
x
|
-1,36
x
|
-2,15
x
|
-2,54
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
1.678
x
|
643
x
|
13,9
x
|
7,97
x
|
6,62
x
|
6,26
x
|
3,71
x
|
Bedrijfswaarde/omzet
|
1.291
x
|
611
x
|
-4,11
x
|
7,97
x
|
3,89
x
|
0,17
x
|
2,83
x
|
Bedrijfswaarde/EBITDA
|
-8,26
x
|
-8,26
x
|
0,69
x
|
-2,61
x
|
-1,12
x
|
-0,05
x
|
-1,02
x
|
Bedrijfswaarde/FCF
|
-
|
-15
x
|
-0,41
x
|
-
|
-1,33
x
|
-0,05
x
|
-1,69
x
|
FCF Yield
|
-
|
-6,65%
|
-243%
|
-
|
-75,4%
|
-1.856%
|
-59,1%
|
Price to Book
|
5,1
x
|
9,75
x
|
2.363
x
|
-
|
-30,5
x
|
-3,5
x
|
-
|
Aantal aandelen (in duizenden)
|
35.591
|
37.093
|
41.802
|
42.217
|
42.566
|
-
|
-
|
Referentieprijs
2 |
20,27
|
22,87
|
6,380
|
6,450
|
5,490
|
5,490
|
5,490
|
Datum van publicatie
|
18/03/21
|
10/03/22
|
9/03/23
|
7/03/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
-
|
0,43
|
1,319
|
19,23
|
34,16
|
35,28
|
37,33
|
63
|
EBITDA
1 |
-
|
-67,2
|
-97,51
|
-113,8
|
-104,5
|
-123,1
|
-130,5
|
-175,4
|
Bedrijfsresultaat (EBIT)
1 |
-
|
-68,53
|
-100,7
|
-117,1
|
-107,9
|
-209,1
|
-247,6
|
-265,5
|
Operationele Marge
|
-
|
-15.937,44%
|
-7.637,15%
|
-609,2%
|
-315,93%
|
-592,84%
|
-663,34%
|
-421,41%
|
Resultaat voor belastingen (EBT)
1 |
-
|
-68,8
|
-101,3
|
-108,9
|
-94,2
|
-317,3
|
-258,3
|
-280,1
|
Nettowinst (verlies)
1 |
-51,13
|
-68,8
|
-101,3
|
-108,9
|
-98,43
|
-247
|
-221,2
|
-237,2
|
Nettomarge
|
-
|
-16.000%
|
-7.681,58%
|
-566,27%
|
-288,17%
|
-700,28%
|
-592,74%
|
-376,51%
|
WPA
2 |
-1,410
|
-6,230
|
-2,730
|
-2,620
|
-2,340
|
-4,037
|
-2,552
|
-2,162
|
Free Cash Flow
1 |
-
|
-
|
-53,56
|
192,4
|
-
|
-103,6
|
-115,7
|
-105,4
|
FCF-marge
|
-
|
-
|
-4.060,88%
|
1.000,63%
|
-
|
-293,67%
|
-310,02%
|
-167,33%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
2/10/20
|
18/03/21
|
10/03/22
|
9/03/23
|
7/03/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Omzet
1 |
0,041
|
0,713
|
3,92
|
4,49
|
6,634
|
4,184
|
5,309
|
5,599
|
17,48
|
5,769
|
7,352
|
7,453
|
8,559
|
8,671
|
15
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
-26,26
|
-28,08
|
-27,8
|
-29,19
|
-28,26
|
-31,89
|
-33,32
|
-32,05
|
-17,08
|
-25,46
|
-30,85
|
-31,73
|
-30,46
|
-31,92
|
-
|
Operationele Marge
|
-64.051,22%
|
-3.938,57%
|
-709,29%
|
-650,07%
|
-425,97%
|
-762,09%
|
-627,56%
|
-572,42%
|
-97,73%
|
-441,29%
|
-419,65%
|
-425,67%
|
-355,9%
|
-368,08%
|
-
|
Resultaat voor belastingen (EBT)
1 |
-26,08
|
-29,14
|
-26,91
|
-27,31
|
-25,77
|
-28,89
|
-29,93
|
-28,54
|
-13,61
|
-22,12
|
-24,2
|
-25,4
|
-20,8
|
-27,2
|
-
|
Nettowinst (verlies)
1 |
-26,08
|
-29,14
|
-26,91
|
-27,31
|
-25,77
|
-28,89
|
-30,49
|
-29,49
|
-14,34
|
-24,11
|
-24,64
|
-25,93
|
-27,31
|
-28,73
|
-
|
Nettomarge
|
-63.609,76%
|
-4.087,38%
|
-686,58%
|
-608,31%
|
-388,44%
|
-690,39%
|
-574,27%
|
-526,65%
|
-82,07%
|
-417,85%
|
-335,12%
|
-347,84%
|
-319,08%
|
-331,36%
|
-
|
WPA
2 |
-0,7100
|
-0,7700
|
-0,6500
|
-0,6600
|
-0,6200
|
-0,6900
|
-0,7300
|
-0,7000
|
-0,3400
|
-0,5700
|
-1,740
|
-1,780
|
-0,9950
|
-1,020
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
9/11/21
|
10/03/22
|
9/05/22
|
9/08/22
|
8/11/22
|
9/03/23
|
8/05/23
|
4/08/23
|
2/11/23
|
7/03/24
|
-
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
-
|
166
|
42,8
|
346
|
-
|
96,3
|
227
|
55,2
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
-53,6
|
192
|
-
|
-104
|
-116
|
-105
|
ROE (netto-inkomsten/eigen vermogen)
|
-
|
-
|
-83,4%
|
-225%
|
-
|
-
|
-
|
-
|
ROA (netto-inkomsten/totale activa)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Totale activa
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettoactief per aandeel
2 |
-
|
3,970
|
2,350
|
0
|
-
|
-0,1800
|
-1,570
|
-
|
Cashflow per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
-
|
3,31
|
1,21
|
-
|
4,41
|
4,85
|
3,92
|
Capex/omzet
|
-
|
-
|
251,18%
|
6,29%
|
-
|
12,5%
|
13%
|
6,22%
|
Datum van publicatie
|
2/10/20
|
18/03/21
|
10/03/22
|
9/03/23
|
7/03/24
|
-
|
-
|
-
|
Laatste slotkoers
5,49
USD Gemiddelde koersdoel
13,75
USD Spread / Gemiddelde doel +150,46% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| -14,88% | 234 mln. | | -2,31% | 103 mld. | | +0,56% | 95,28 mld. | | +1,69% | 22,15 mld. | | -17,37% | 21,02 mld. | | -9,30% | 18,15 mld. | | -41,01% | 16,73 mld. | | -14,85% | 16,05 mld. | | +3,21% | 13,68 mld. | | +33,54% | 12,17 mld. |
Biotherapeutische geneesmiddelen
|